LHC Group (LHCG) Expected to Post Q1 2019 Earnings of $0.66 Per Share
LHC Group (NASDAQ:LHCG) – Research analysts at SunTrust Banks issued their Q1 2019 earnings per share estimates for shares of LHC Group in a report issued on Thursday. SunTrust Banks analyst D. Macdonald forecasts that the health services provider will post earnings per share of $0.66 for the quarter. SunTrust Banks also issued estimates for LHC Group’s Q2 2019 earnings at $0.72 EPS.
Other analysts have also recently issued reports about the stock. Royal Bank Of Canada reaffirmed a “buy” rating on shares of LHC Group in a research note on Tuesday, June 13th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $65.00 target price on shares of LHC Group in a research note on Friday, June 9th. Benchmark Co. lifted their target price on shares of LHC Group from $63.00 to $72.00 and gave the stock a “buy” rating in a research note on Thursday, June 8th. BidaskClub cut shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. Finally, Bank of America Corporation started coverage on shares of LHC Group in a research note on Monday, August 21st. They issued a “buy” rating and a $76.00 target price for the company. One analyst has rated the stock with a hold rating and ten have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $66.60.
COPYRIGHT VIOLATION NOTICE: “LHC Group (LHCG) Expected to Post Q1 2019 Earnings of $0.66 Per Share” was originally published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/09/18/lhc-group-lhcg-expected-to-post-q1-2019-earnings-of-0-66-per-share.html.
LHC Group (NASDAQ:LHCG) opened at 65.57 on Monday. LHC Group has a 12-month low of $32.04 and a 12-month high of $69.35. The company has a 50-day moving average price of $63.46 and a 200-day moving average price of $59.66. The firm has a market capitalization of $1.20 billion, a PE ratio of 29.01 and a beta of 0.76.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The firm had revenue of $260.20 million for the quarter, compared to analysts’ expectations of $254.10 million. During the same period in the prior year, the firm posted $0.52 earnings per share. The firm’s quarterly revenue was up 15.1% on a year-over-year basis.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 14.80% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in LHCG. Federated Investors Inc. PA grew its stake in shares of LHC Group by 4.2% during the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after buying an additional 66 shares during the period. Acrospire Investment Management LLC grew its stake in shares of LHC Group by 30.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after buying an additional 400 shares during the period. Cubist Systematic Strategies LLC grew its stake in shares of LHC Group by 758.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after buying an additional 1,516 shares during the period. Invictus RG purchased a new stake in shares of LHC Group during the 1st quarter valued at $125,000. Finally, US Bancorp DE grew its stake in shares of LHC Group by 25.1% during the 1st quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after buying an additional 539 shares during the period. 85.93% of the stock is owned by institutional investors.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.